SYNAGIS (Palivizumab) for Respiratory Syncytial Virus (RSV) in 7MM: Market Size, Forecasts, and Emerging Insights 2019-2023 & 2023-2032
April 30, 2024 04:34 ET
|
Research and Markets
Dublin, April 30, 2024 (GLOBE NEWSWIRE) -- The "SYNAGIS Market Size, Forecast, and Market Insight - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
High Prevalence of RSV in Infants and Elderly Pushes RSV Vaccine and Antibody Market Growth - Forecast to 2030
September 28, 2023 04:58 ET
|
Research and Markets
Dublin, Sept. 28, 2023 (GLOBE NEWSWIRE) -- The "Global Respiratory Syncytial Virus (RSV) Vaccine And Antibody Pipeline Market: Forecast up to 2030" report has been added to ResearchAndMarkets.com's...
World RSV Vaccine and Antibody Pipeline Market Report 2022 - Growing Instances of RSV Among Infants
May 13, 2022 07:23 ET
|
Research and Markets
Dublin, May 13, 2022 (GLOBE NEWSWIRE) -- The "Global Respiratory Syncytial Virus Vaccine And Antibody Pipeline Market: Analysis By End User, By Type, By Region, Size and Trends with Impact of...
Global Respiratory Syncytial Virus Markets, 2017-2020 & 2021-2027 - Increasing Disease Burden / Advent of Targeted Therapies / High Cost of Disease Management
August 31, 2021 07:13 ET
|
Research and Markets
Dublin, Aug. 31, 2021 (GLOBE NEWSWIRE) -- The "Global Respiratory Syncytial Virus Market Size and Epidemiology (8MM), By Drug Type (Synagis, Other), By Dosage Form (Oral, Other), By Treatment Type...